MétaCan
Menu
← Back to cohort

MP53-18 PROSTATE SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY FOR THE IDENTIFICATION OF INTRA-PROSTATIC TUMORS: INVESTIGATING DELINEATION GUIDELINES FOR FOCAL THERAPY AND GUIDED BIOPSY

2020· article· en· W3021678061 on OpenAlexaboutno aff
Ryan Alfano, Glenn Bauman, Jonathan D. Thiessen, Irina Rachinsky, William Pavlosky, John Butler, Madeleine Moussa, Jose A. Gomez-Lemus, Mena Gaed, Stephen E. Pautler, Joseph L. Chin, Aaron D. Ward

Bibliographic record

VenueThe Journal of Urology · 2020
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Treatment and Research
Canadian institutionsnot available
Fundersnot available
KeywordsMedicinePositron emission tomographyProstate cancerProstatectomyBiopsyConcordanceGlutamate carboxypeptidase IIProstate-specific antigenRadiologyNuclear medicineCancerInternal medicine

Abstract

fetched live from OpenAlex

You have accessJournal of UrologyProstate Cancer: Localized: Radiation Therapy (MP53)1 Apr 2020MP53-18 PROSTATE SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY FOR THE IDENTIFICATION OF INTRA-PROSTATIC TUMORS: INVESTIGATING DELINEATION GUIDELINES FOR FOCAL THERAPY AND GUIDED BIOPSY Ryan Alfano*, Glenn Bauman, Jonathan Thiessen, Irina Rachinsky, William Pavlosky, John Butler, Madeleine Moussa, Jose Gomez-Lemus, Mena Gaed, Stephen Pautler, Joseph Chin, and Aaron Ward Ryan Alfano*Ryan Alfano* More articles by this author , Glenn BaumanGlenn Bauman More articles by this author , Jonathan ThiessenJonathan Thiessen More articles by this author , Irina RachinskyIrina Rachinsky More articles by this author , William PavloskyWilliam Pavlosky More articles by this author , John ButlerJohn Butler More articles by this author , Madeleine MoussaMadeleine Moussa More articles by this author , Jose Gomez-LemusJose Gomez-Lemus More articles by this author , Mena GaedMena Gaed More articles by this author , Stephen PautlerStephen Pautler More articles by this author , Joseph ChinJoseph Chin More articles by this author , and Aaron WardAaron Ward More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000915.018AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Prostate specific membrane antigen positron emission tomography (PSMA PET) has shown good concordance with histology in involved sextants, but there is a need, addressed in this study, to investigate the ability of PSMA PET to delineate dominant intraprostatic lesion (DIL) boundaries for guided biopsy and focal therapy planning. METHODS: We registered pathologist-annotated whole-mount mid-gland prostatectomy histology sections from 12 patients to pre-surgical PSMA PET/MRI scans using our previously published accurate method. We generated PET derived tumor volumes using boundaries defined by thresholded PET volumes from 1–100% of max SUV in 1% intervals. At each interval, we applied a margin of 0–30 voxels in one voxel increments, giving 3,000 volumes per patient. We calculated sensitivity and specificity for cancer detection within the 2D oblique histologic planes that intersected with the 3D PET volume for each patient. We determined the threshold and margin combination that satisfied the following criteria: ≥95% sensitivity with max specificity (supporting focal therapy) and ≥95% specificity with max sensitivity (supporting guided biopsy). RESULTS: Figure 1 shows histologic cancer sensitivity (left) and specificity (right) as a function of SUV threshold and expansion margin. A threshold of 67% SUV max with an 8.4 mm margin (white circle) achieved a (mean ± std.) sensitivity of 95.0 ± 7.8% and specificity of 76.4 ± 14.7%. A threshold of 81% SUV max with a 5.1 mm margin (white diamond) achieved sensitivity of 65.1 ± 28.4% and specificity of 95.1 ± 5.2%. CONCLUSIONS: This study used accurate co-registration of PSMA PET/MRI and histopathology to determine SUV thresholds and margin expansions having high sensitivity, supporting focal therapy, and high specificity, supporting guided biopsy. These parameters can be used in a larger validation study supporting clinical translation. Source of Funding: Prostate Cancer Canada, Natural Sciences and Engineering Research Council, Canadian Institutes of Health Research, Ontario Institute for Cancer Research © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e789-e790 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Ryan Alfano* More articles by this author Glenn Bauman More articles by this author Jonathan Thiessen More articles by this author Irina Rachinsky More articles by this author William Pavlosky More articles by this author John Butler More articles by this author Madeleine Moussa More articles by this author Jose Gomez-Lemus More articles by this author Mena Gaed More articles by this author Stephen Pautler More articles by this author Joseph Chin More articles by this author Aaron Ward More articles by this author Expand All Advertisement PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.012
metaresearch head score (Gemma)0.027
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.012
Threshold uncertainty score0.062

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0120.027
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0030.001
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0010.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0080.006

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.146
GPT teacher head0.383
Teacher spread0.236 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueThe Journal of Urology→Same topicProstate Cancer Treatment and Research→French-language works237,207→